These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15032718

  • 1. Farnesylated proteins as anticancer drug targets: from laboratory to the clinic.
    Russo P, Loprevite M, Cesario A, Ardizzoni A.
    Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):123-38. PubMed ID: 15032718
    [Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitors: potential role in the treatment of cancer.
    Cox AD.
    Drugs; 2001 Mar; 61(6):723-32. PubMed ID: 11398905
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evolving therapies: farnesyltransferase inhibitors.
    Purcell WT, Donehower RC.
    Curr Oncol Rep; 2002 Jan; 4(1):29-36. PubMed ID: 11734111
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Development of farsenyl transferase inhibitors as anticancer agents].
    Cestac P, Doisneau-Sixou S, Favre G.
    Ann Pharm Fr; 2005 Jan; 63(1):76-84. PubMed ID: 15803104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues.
    Sebti SM, Hamilton AD.
    Expert Opin Investig Drugs; 2000 Dec; 9(12):2767-82. PubMed ID: 11093352
    [Abstract] [Full Text] [Related]

  • 16. Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002.
    Caponigro F.
    Anticancer Drugs; 2002 Sep; 13(8):891-7. PubMed ID: 12394276
    [Abstract] [Full Text] [Related]

  • 17. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.
    Du W, Lebowitz PF, Prendergast GC.
    Mol Cell Biol; 1999 Mar; 19(3):1831-40. PubMed ID: 10022870
    [Abstract] [Full Text] [Related]

  • 18. Farnesyltransferase inhibitors.
    Sebti SM, Adjei AA.
    Semin Oncol; 2004 Feb; 31(1 Suppl 1):28-39. PubMed ID: 14981578
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Ras prenylation: a novel approach to cancer chemotherapy.
    Sebti SM, Hamilton AD.
    Pharmacol Ther; 1997 Feb; 74(1):103-14. PubMed ID: 9336018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.